Stay updated on ALD403 Safety Tolerability Pharmacokinetics in Clinical Trial
Sign up to get notified when there's something new on the ALD403 Safety Tolerability Pharmacokinetics in Clinical Trial page.

Latest updates to the ALD403 Safety Tolerability Pharmacokinetics in Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now lists Victoria as a location and shows an updated revision to v3.3.3. The HHS Vulnerability Disclosure entry and the Victoria Locations subsection have been removed.SummaryDifference0.2%

- Check22 days agoNo Change Detected
- Check36 days agoChange Detected- Revision updated from v3.3.1 to v3.3.2. This is a minor site framework update and does not affect study details or user-facing content.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page revision tag was updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check50 days agoChange DetectedGeneral funding/operational notice was removed from the page; study details and trial information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check64 days agoChange DetectedNo substantive changes to study details were observed; the updates appear to be minor UI adjustments, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check93 days agoChange DetectedUpgraded to version v3.2.0 with a funding-status notice about operational limitations; v3.1.0 was removed. Indicates a maintenance/availability update rather than new content.SummaryDifference5%

Stay in the know with updates to ALD403 Safety Tolerability Pharmacokinetics in Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALD403 Safety Tolerability Pharmacokinetics in Clinical Trial page.